Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Shares of Eli Lilly & Co. LLY advanced 1.11% to $915.04 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 and ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 586.36% and ...

Replacing 10 percent of ultra-processed foods with healthier alternatives lowered diabetes risk by up to 18 percent, a new study says.

Dairy and meat don’t have to induce guilt—or climate change—as farming is about to change. From the world’s largest food ...

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker ...

A good example is the healthcare sector. It has been out of favour for a few years and valuations are attractive. Yet the fundamentals continue to be sound, if not improving, and concerns are ...

Eli Lilly stock may look expensive, but that may not be the case in a few years as the business grows at a rapid pace.